BioLife Solutions, Inc.
BLFS
$21.91
-$0.35-1.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 183.30% | 94.15% | -- | 25.47% | 69.59% |
| Total Depreciation and Amortization | 35.76% | -27.07% | -- | -28.36% | -171.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | -171.94% | -77.07% | -- | -26.95% | -71.28% |
| Change in Net Operating Assets | -84.02% | 39.59% | -- | -378.95% | 20.40% |
| Cash from Operations | -28.82% | 209.66% | 183.69% | -65.01% | -70.59% |
| Capital Expenditure | 66.36% | 35.42% | -- | 80.91% | 58.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,073.93% | -103.28% | -- | -91.71% | 169.08% |
| Cash from Investing | 1,760.93% | -201.14% | -244.59% | -107.55% | 126.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,951.89% | -535.60% | -- | -89.76% | 520.45% |
| Issuance of Common Stock | -99.37% | -28.13% | -- | -- | 64,781.25% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 67.56% | -- | -26.96% | -21.44% |
| Cash from Financing | -141.52% | -271.22% | -200.00% | -69.40% | 1,674.56% |
| Foreign Exchange rate Adjustments | -53.97% | 164.29% | -- | -690.91% | -7.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 340.42% | 197.74% | -434.64% | -1,595.25% | 312.96% |